Home
>
National Drug Code (NDC)
>
Ancobon
Ancobon - 55154-6575-0 - (flucytosine)
Drug Information of Ancobon
| Product NDC: | 55154-6575 |
| Proprietary Name: | Ancobon |
| Non Proprietary Name: | flucytosine |
| Active Ingredient(s): | 500 mg/1 & nbsp; flucytosine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ancobon
| Product NDC: | 55154-6575 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017001 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820101 |
Package Information of Ancobon
| Package NDC: | 55154-6575-0 |
| Package Description: | 10 POUCH in 1 BAG (55154-6575-0) > 1 CAPSULE in 1 POUCH |
NDC Information of Ancobon
| NDC Code | 55154-6575-0 |
| Proprietary Name | Ancobon |
| Package Description | 10 POUCH in 1 BAG (55154-6575-0) > 1 CAPSULE in 1 POUCH |
| Product NDC | 55154-6575 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | flucytosine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19820101 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | FLUCYTOSINE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] |
